Home › Triple-Negative Breast Cancer › Utah › West Valley City
Triple-Negative Breast Cancer clinical trials in West Valley City, UT
13 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around West Valley City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- START Mountain Region, West Valley City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- START Mountain Region, West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- START Mountain Region, West Valley City
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Start Mountain Region /ID# 276270, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- START Mountain Region, LLC, West Valley City
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
RecruitingPhase 1
- START Mountain Region, West Valley City
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in West Valley City
- Non-Small Cell Lung Cancer25 studies
- Colorectal Cancer17 studies
- Breast Cancer13 studies
- Metastatic Cancer13 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Ovarian Cancer11 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Endometrial Cancer10 studies
- Stomach Cancer8 studies
- Esophageal Squamous Cell Carcinoma7 studies
- Small Cell Lung Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.